15 years of revenue, profit, cash flow and balance-sheet history through FY2025,
from SEC filings — with a computed, factual read of the trend.
Updated Overview →
Growth & profitability
Revenue has grown 1.1% per year over the past 5 years.
Net income has grown slower than revenue (-2.9% vs 1.1% per year).
Free cash flow has declined 10.0% per year over the past 5 years.
Financial health
Total debt ($2.5B) exceeds cash ($167M); net debt is $2.3B.
Total debt has grown slower than revenue (-2.2% vs 1.1% per year).
Shareholder returns
Dividends have been paid for 15 consecutive years, consuming 74.3% of earnings and 79.1% of free cash flow.
The dividend has grown 2.5% per year over the past 5 years.
Revenue & net income
RevenueNet income
Margins (gross / operating / net)
GrossOperatingNet
Free cash flow (CFO − capex)
Free cash flow
Cash vs total debt
CashTotal debt
Cash flow: operating / investing / financing
OperatingInvestingFinancing
Key annual figures
FY
Revenue
Net income
Gross M
Op M
FCF
Total debt
Cash
2025
$7.1B
$810M
45.2%
0.0%
$761M
$2.5B
$167M
2024
$7.1B
$280M
43.0%
0.0%
$483M
$2.5B
$202M
2023
$7.4B
$149M
39.4%
0.0%
$930M
$2.5B
$367M
2022
$7.1B
$462M
35.8%
0.0%
$535M
$2.7B
$183M
2021
$7.3B
$710M
43.6%
0.0%
$945M
$2.8B
$319M
2020
$6.7B
$939M
45.6%
0.0%
$1.3B
$2.8B
$871M
2019
$6.2B
$820M
43.9%
0.0%
$786M
$2.7B
$111M
2018
—
$823M
—
—
$782M
$2.5B
$131M
2017
—
$701M
—
—
$634M
$2.2B
$418M
2016
—
$648M
—
—
$606M
$2.3B
$401M
2015
—
$580M
—
—
$749M
$2.2B
$382M
2014
—
$558M
—
—
$630M
$2.3B
$329M
2013
—
$572M
—
—
$585M
$2.4B
$299M
2012
—
$541M
—
—
$423M
$2.7B
$267M
2011
—
$557M
—
—
$470M
$2.6B
$259M
Revenue & net income
RevenueNet income
Margins (gross / operating / net)
GrossOperatingNet
Free cash flow (CFO − capex, quarterly)
Free cash flow
Cash vs total debt
CashTotal debt
Cash flow: operating / investing / financing
OperatingInvestingFinancing
Key quarterly figures
Quarter
Revenue
Net income
Gross M
Op M
FCF
Total debt
Cash
Mar '26
$1.7B
$187M
43.2%
0.0%
-$165M
$4.1B
$1.2B
Dec '25
$1.7B
$157M
43.2%
0.0%
$269M
$2.8B
$227M
Sep '25
$1.4B
$80M
41.7%
0.0%
$57M
$2.7B
$166M
Jun '25
$2.0B
$332M
46.5%
0.0%
$219M
$2.5B
$167M
Mar '25
$1.7B
$186M
44.6%
0.0%
$233M
$2.5B
$226M
Dec '24
$1.7B
$193M
43.8%
0.0%
$127M
$2.7B
$290M
Sep '24
$1.8B
$99M
45.8%
0.0%
$182M
$2.5B
$278M
Jun '24
$1.9B
$216M
46.5%
0.0%
$259M
$2.5B
$202M
Mar '24
$1.8B
-$51M
42.2%
0.0%
$127M
$2.6B
$219M
Dec '23
$2.0B
$93M
43.5%
0.0%
$101M
$2.7B
$355M
Sep '23
$1.4B
$22M
38.4%
0.0%
-$4M
$2.8B
$518M
Jun '23
$2.0B
$176M
42.7%
0.0%
$346M
$2.5B
$367M
Mar '23
$1.9B
-$211M
41.8%
0.0%
$285M
$2.6B
$242M
Dec '22
$1.7B
$99M
36.2%
0.0%
$167M
$2.7B
$168M
Sep '22
$1.7B
$85M
36.0%
0.0%
$132M
$2.8B
$278M
Jun '22
$1.8B
$101M
37.1%
0.0%
$256M
$2.7B
$183M
Mar '22
$1.8B
$150M
35.9%
0.0%
$166M
$2.9B
$241M
Dec '21
$1.7B
$69M
33.0%
0.0%
$124M
$2.9B
$192M
Sep '21
$1.8B
$142M
37.1%
0.0%
-$11M
$2.9B
$210M
Jun '21
$1.8B
$97M
37.1%
0.0%
$284M
$2.8B
$319M
Valuation over time
How the market has priced CLX against its own fundamentals since 2023-03 —
each month-end's share price set against the most recent annual filing, so the multiple moves
as price runs ahead of (or behind) earnings. Split-adjusted.
The price-to-earnings ratio has fallen from 41.4× (Mar '23) to 14.2× (Jun '26).
The price-to-sales ratio has fallen from 2.7× (Mar '23) to 1.6× (Jun '26).
The dividend yield has risen from 3.0% (Mar '23) to 5.2% (Jun '26).
Price / earnings (P/E)
P/E
Price / sales (P/S)
P/S
Dividend yield (%)
Dividend yield %
Frequently asked questions
Is CLX growing its revenue and profit?
Over the past 5 years, Clorox's revenue has grown 1.1% per year, and net income declined 2.9% per year. These are computed facts, not advice.
How much debt does CLX have?
As of FY2025, Clorox reported $2.5B of total debt against $167M of cash.
What is CLX's profit margin?
In FY2025, gross margin was 45.2%, operating margin —, and net margin 11.4%.
What is CLX's P/E ratio?
As of Jun '26, Clorox traded at a price-to-earnings ratio of about 14.2× (market cap ÷ latest annual net income). The valuation charts above show how its P/E, P/S and dividend yield have moved with the share price. These are computed facts, not advice.
Where does this data come from?
All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.
Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted ·
growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price
against the latest annual filing. Informational only — not investment advice.